455P Post progression treatments after endocrine therapy (ET) plus palbociclib in patients with HR+/HER2- metastatic breast cancer (MBC): A prospective, real-world study
| Autor: | Palumbo, R., Saltalamacchia, G., Quaquarini, E., Tagliaferri, B., Teragni, C.M., Barletta, C., Frascaroli, M., Biscaldi, E., Malovini, A., Locati, L.D., Sottotetti, F. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S372-S372 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|